Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs
sxgoo.com

See what CB Insights has to offer

Stage

IPO | IPO

Total Raised

$10.29M

Date of IPO

5/10/2017

About Shouxiangu

Provider of traditional Chinese medicines. The company specializes in traditional Chinese medicines utilizing herbs and mushrooms for human use. Its primary product includes ganoderma lucidum spore powder.

Shouxiangu Headquarter Location

10 Shangcheng Road Hushan Street

321200,

China

86 579 87622285

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Shouxiangu

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Shouxiangu is included in 1 Expert Collection, including Biopharmaceuticals.

B

Biopharmaceuticals

5,732 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.